Related Experiment Video
Updated: Jul 4, 2025
04:33
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
684
Does a program-based cognitive behavioral therapy affect insomnia and depression in menopausal women? A randomized
Ahmed Hashem El-Monshed1,2, Leena Mohamed Khonji3, Marwan Altheeb1
1Department of Nursing, College of Health and Sport Sciences, University of Bahrain, Manama, Bahrain.
Worldviews on Evidence-Based Nursing
|February 8, 2024
Summary
Cognitive behavioral group therapy (CBT) effectively reduced insomnia and depression in menopausal women. This safe intervention can help manage sleep and emotional issues during menopause.
Area of Science:
- Menopause research
- Psychological interventions
- Sleep science
Background:
- Menopausal syndrome encompasses physical and psychological symptoms due to hormonal fluctuations, sleep disturbances, and mood swings.
- Effective interventions are needed to manage these symptoms in menopausal women.
Purpose of the Study:
- To evaluate the efficacy of a program-based cognitive behavioral group therapy (CBT) for insomnia and depression in menopausal women.
Main Methods:
- A randomized controlled trial involving 88 menopausal women in Egypt.
- Participants were assigned to a control group or an intervention group receiving 7 weeks of CBT sessions.
- Insomnia Severity Index (ISI), Pittsburgh Sleep Quality Index (PSQI), and Beck Depression Inventory (BDI-II) were used for assessment.
Main Results:
- The intervention group showed significant improvements in PSQI subdomains (sleep efficiency, daytime dysfunction, subjective sleep quality, sleep disturbance).
- Significant pre- and post-intervention improvements were noted in total scores for PSQI, ISI, and BDI-II within the intervention group.
- Large effect sizes (r = .81–.87) were observed for these improvements.
Conclusions:
- Group CBT is effective in reducing insomnia and depression among menopausal women.
- CBT is a safe and recommended intervention to prevent the worsening of sleep and emotional problems in this population.
Related Concept Videos
01:19Management of Insomnia
248
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
248
01:27Insomnia
85
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
85
01:54The Placebo Effect
6.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.2K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
175
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
175
01:25Cognitive Therapy
152
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
152
01:23Antidepressant Drugs: MAOIs and Other Agents
230
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
230